Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 39 for “"Modified mRNA"”.

  1. Toward Controlling Cardiac Tissue Pacing Using Modified mRNA

    … lights. To deliver ReaChR into micro tissues, modified mRNA is chosen because of its higher transfection rate comparing to the plasmid, and lower cell toxicity comparing to the virus. Reducible polycation (RPC) is synthesized and used as transfection reagent to acquire a better transfection …

    wustl Repository record for Toward Controlling Cardiac Tissue Pacing Using Modified mRNA (opens in a new tab)

  2. Synthesis, Characterization, and Biomedical Applications of Polysaccharide-Modified mRNA-Lipid Nanoparticles

    Messenger RNA (mRNA) therapeutics have emerged as a transformative platform for vaccination, protein replacement therapy, gene editing, and cancer immunotherapy. Despite their rapid clinical advancement, broader implementation of mRNA technologies remains limited by challenges associated with …

    oklahoma-thes Repository record for Synthesis, Characterization, and Biomedical Applications of Polysaccharide-Modified mRNA-Lipid Nanoparticles (opens in a new tab)

  3. Cardiomyocyte-Specific Modified Mrna For Myocardial Regeneration In A Porcine Myocardial Infarction Model

    … notable approach is the utilization of modified mRNA (modRNA), which provides a safe, controlled, transient, non-viral, and clinically relevant means of gene delivery. The study was conducted using a novel cardiomyocyte specific modRNA translational system (CM SMRTs) that could …

    uab Repository record for Cardiomyocyte-Specific Modified Mrna For Myocardial Regeneration In A Porcine Myocardial Infarction Model (opens in a new tab)

  4. Cardiomyocyte-Specific Modified mRNA For Myocardial Regeneration In A Porcine Myocardial Infarction Model

    … notable approach is the utilization of modified mRNA (modRNA), which provides a safe, controlled, transient, non-viral, and clinically relevant means of gene delivery. The study was conducted using a novel cardiomyocyte specific modRNA translational system (CM SMRTs) that could …

    uab Repository record for Cardiomyocyte-Specific Modified mRNA For Myocardial Regeneration In A Porcine Myocardial Infarction Model (opens in a new tab)

  5. DEVELOPMENT OF A VACCINE FOR LYME DISEASE USING THE NUCLEOSIDE-MODIFIED mRNA-LNP PLATFORM

    … the lipid nanoparticle-encapsulated nucleoside-modified mRNA (mRNA-LNP) platform to generate a Lyme disease vaccine like the successful clinical vaccines against SARS-CoV-2. Of the antigens expressed by Borrelia burgdorferi, the causative agent of Lyme disease, outer surface protein A (OspA) is …

    penn Repository record for DEVELOPMENT OF A VACCINE FOR LYME DISEASE USING THE NUCLEOSIDE-MODIFIED mRNA-LNP PLATFORM (opens in a new tab)

  6. Translation of angiotensin converting enzyme 2 (ACE2) upon liver and lung targeted delivery of optimized chemically modified mRNA

    … this purpose, in vitro transcribed chemically modified ACE2 mRNA (cmRNA) was designed and profound in vitro cmRNA transfection efficiency, protein expression and activity was shown. With the aim of organ targeted ACE2 protein expression, close investigations about protein maturation were …

    lmu-germany Repository record for Translation of angiotensin converting enzyme 2 (ACE2) upon liver and lung targeted delivery of optimized chemically modified mRNA (opens in a new tab)

  7. An mRNA-reprogramming method with improved kinetics and efficiency and the successful transdifferentiation of human fibroblasts using modified mRNA

    … mediated through the delivery of exogenous mRNAs encoding OCT4, SOX2, KLF4 and cMYC is a fast and efficient method for generating integration-free iPS cells. Here we show that mRNA reprogramming can be enhanced further by employing an mRNA dose-ramping approach that provides greater control …

    whiterose Download PDF for An mRNA-reprogramming method with improved kinetics and efficiency and the successful transdifferentiation of human fibroblasts using modified mRNA (opens in a new tab)

  8. UNTANGLING THE ADJUVANTICITY OF MRNA VACCINES: NUCLEOSIDE-MODIFIED MRNA AND LIPID NANOPARTICLES COOPERATE TO DRIVE T FOLLICULAR HELPER CELL RESPONSES

    … pandemic, the utility of the messenger RNA (mRNA) vaccine platform has become increasingly evident due to its ease of adaptability to target emerging viral variants as well as its ability to drive potent humoral responses. Data from our group has shown that these potent humoral immune …

    penn Repository record for UNTANGLING THE ADJUVANTICITY OF MRNA VACCINES: NUCLEOSIDE-MODIFIED MRNA AND LIPID NANOPARTICLES COOPERATE TO DRIVE T FOLLICULAR HELPER CELL RESPONSES (opens in a new tab)

  9. Brucella and Coronavirdae Subversion of Novel Blos1-Directed Immune Defense

    … IRE1α-dependent decay (RIDD) of Bloc1s1 mRNA encoding Blos1, a protein that promotes endosome-lysosome fusion. RIDD-deficient cells and mice harboring a RIDD-incompetent variant of IRE1α were resistant to infection. Inactivation of the Bloc1s1 gene impaired the ability to assemble …

    tamu Repository record for Brucella and Coronavirdae Subversion of Novel Blos1-Directed Immune Defense (opens in a new tab)

  10. DEVELOPMENT OF A LIPID NANOPARTICLE-ENCAPSULATED mRNA VACCINE AGAINST CLOSTRIDIUM DIFFICILE INFECTION

    … a lipid nanoparticle-encapsulated, nucleoside-modified mRNA (mRNA-LNP) vaccine against CDI. The mRNA encoded one truncated fragment of the receptor binding domain (RBD) of C. difficile Toxin A. We assessed both humoral and cell-mediated immune responses in mice following immunization. Results …

    cornell Repository record for DEVELOPMENT OF A LIPID NANOPARTICLE-ENCAPSULATED mRNA VACCINE AGAINST CLOSTRIDIUM DIFFICILE INFECTION (opens in a new tab)

  11. Modifying the makers: release factor hydroxylation, non-canonical nucleosides, and their influence on translation

    … amenable to adaptation for a wide variety of modified nucleosides was developed; its application revealed successful incorporation of three non-canonical nucleotides in substantial amounts: 7-deazaadenosine (7-Deaza-A), N6-methyladenosine (m6A), and 2-fluoroadenosine (2-F-A). Their effects on …

    freiburg-diss Repository record for Modifying the makers: release factor hydroxylation, non-canonical nucleosides, and their influence on translation (opens in a new tab)

  12. The Effect Of Maternal Antibodies On Anti-Viral Immunity In Infant Mice

    … we show that a novel vaccine, nucleoside-modified mRNA encapsulated in lipid nanoparticles (mRNA-LNP) encoding influenza hemagglutinin, overcomes maternal antibody inhibition by prolonged establishment of germinal centers. mRNA-LNP vaccination offers a promising means of eliciting …

    penn Repository record for The Effect Of Maternal Antibodies On Anti-Viral Immunity In Infant Mice (opens in a new tab)

  13. Project 1 Molecular genetic analysis of m6A methylation of mRNA in a Drosophila Model Project 2 Development of a phenotypic highthroughput-screening assay to identify novel molecules that inhibit Mycobacteria

    … Various pathways regulate the process of mRNA synthesis into proteins among which methylation is an important one. Internal methylation has known regulate alternate splicing and regulate neuronal development. Knocking out genes involved in synthesis of proteins binding to methylated sites …

    birmingham Download PDF for Project 1 Molecular genetic analysis of m6A methylation of mRNA in a Drosophila Model Project 2 Development of a phenotypic highthroughput-screening assay to identify novel molecules that inhibit Mycobacteria (opens in a new tab)

  14. Human primary and iPSC-derived hepatocyte cell therapies to treat liver disease

    … factor (EGF) in hepatocytes via nucleoside-modified mRNA encapsulated in lipid nanoparticles (mRNA-LNP) in mice. We confirm specific hepatotropism of intravenous injected mRNA-LNP, with protein expression lasting about three days. In the liver, virtually all hepatocytes are transfected along …

    bu Repository record for Human primary and iPSC-derived hepatocyte cell therapies to treat liver disease (opens in a new tab)

  15. Use of Cell- and Gene-Based Therapies for Providing Cardiac Biological Pacing

    … therapies, I used in vitro transcribed modified mRNA, encoding the transcription factor T-box18 to reprogram chamber cardiomyocytes into induced pacemaker cells. I demonstrated the health and safety benefits in vivo of using mRNA for gene transfer, rather than traditional recombinant …

    gatech Repository record for Use of Cell- and Gene-Based Therapies for Providing Cardiac Biological Pacing (opens in a new tab)

  16. Molecular toolbox for characterizing, preventing, and treating human respiratory syncytial virus infections

    … microtubule-mediated process. We used synthetic, modified mRNA to express engineered broadly neutralizing antibodies to prevent RSV infection. We developed the use of both secreted and membrane-anchored palivizumab that prevents RSV infection in vitro and in the lungs of mice. We showed that …

    gatech Repository record for Molecular toolbox for characterizing, preventing, and treating human respiratory syncytial virus infections (opens in a new tab)

  17. Generation Of Cardiac Myocyte Synthetic 5’ Untranslated mRNA For Translation Therapy

    … revive a failing heart. Therapeutic delivery of mRNA to the heart for recovery is a good approach, with a process that also guarantees optimal bioavailability of the therapy to the intended target. Using a reporter assay system, we showed an improved protein expression using modified mRNA. We …

    houston Repository record for Generation Of Cardiac Myocyte Synthetic 5’ Untranslated mRNA For Translation Therapy (opens in a new tab)

  18. Improved Myocardial Infarct Repair Via Cardiac Tissue Engineering and Modified RNA

    … repair via cardiac tissue engineering and modified RNA. First of all, we generated human induced pluripotent stem cells (iPSCs) from ventricular and atrial fibroblasts by Sendai virus overexpressing four Yamanaka factors, and then characterized and compared the two iPSCs. Electrophysiology …

    uab Repository record for Improved Myocardial Infarct Repair Via Cardiac Tissue Engineering and Modified RNA (opens in a new tab)

  19. Design, Testing, and Optimization of a Preclinical mRNA-LNP Vaccine for Hepatitis C Virus Prophylaxis

    … developments with advances in the nucleoside-modified mRNA lipid nanoparticle (mRNA-LNP) vaccine platform. We evaluated structural and nonstructural viral proteins in our vaccine constructs, demonstrating that encoding p7 along with core (C), envelope glycoprotein 1 (E1), and envelope …

    penn Repository record for Design, Testing, and Optimization of a Preclinical mRNA-LNP Vaccine for Hepatitis C Virus Prophylaxis (opens in a new tab)

Page 1 of 2